Parkinson's Disease Trial, Recruiting NCT06791902 Sponsor: Jocelyne Bloch Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06791902
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with typical or atypical forms of Parkinson's disease and who experience difficulties with walking or balance.
  • People who have had a specific set of Medtronic brain stimulation devices implanted, including a Percept PC or Percept RC neurostimulator, bilateral leads (certain Medtronic Legacy or SenSight models), and compatible lead extensions or connector plug.
  • People whose brain signal recordings show changes in at least one frequency range that are linked to walking patterns or gait difficulties.
  • People aged 18 years or older.
  • People who are willing to read, understand, and sign an informed consent form before any study procedures begin.
  • People who are able to understand and communicate with the study team in French.
  • People who agree to follow all recording conditions and attend all required study visits.

Who may not be able to join:

  • People whose brain stimulation device is set to a mode that is not compatible with adaptive deep brain stimulation (confirm with trial site).
  • People whose brain signal recordings show high interference or technical problems that prevent detection of movement-related signals.
  • People who do not tolerate changes in the strength of their brain stimulation.
  • People whose walking difficulties are caused by conditions other than Parkinson's disease.
  • People who are unable to follow the study procedures on their own.
  • People with a history of significant psychiatric illness or major cognitive impairment, as assessed by the study investigators and treating doctors.
  • People who have major changes to their Parkinson's disease treatments planned during the study period.
  • People with a history of drug or alcohol misuse in the past 5 years.
  • People who are pregnant.
  • People who have taken part in another research study in the 30 days before this trial or who are currently in another research study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41 79 556 2951

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jocelyne Bloch
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov